Back
Results - Announcements
Sanjivani Paranteral Ltd consolidated sales up 80.47% on year in Q2FY2026, net profit soared by 352.73%
14-Aug-2026, 05:35
Sanjivani Paranteral Ltd share price inched up 2.93% to Rs 191.45 after the company's net profit saw a strong growth of 352.73% to Rs 2.49 crore, while revenue from operations increased sharply by 80.47% to Rs 23.84 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.19 lakh crore, rising 4.69%. It has marginally improved by 0.66% over last one week and climbed by 11.20% in last one month while the market capitalization of Sanjivani Paranteral Ltd has slipped by 0.91% and 40.46% in the same period respectively. Profit before tax (PBT) of Sanjivani Paranteral Ltd stood at Rs 3.32 crore in Q2 FY26, rallying 44.35% year-on-year, and surging by 176.67% quarter-on-quarter. EBITDA came in at Rs 4 crore, expanding by 54.62% YoY and jumping 310.20% sequentially. Total expenses surged 65.34% to Rs 20.32 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 15.67 crore, witnessing a sharp rise of 110.34% YoY, while employee benefits expense was at Rs 2.35 crore, easing 4.91% YoY. For the TTM ended FY26, revenue from operations jumped by 28.84% to Rs 70.1 crore, while net profit jumped 31.12% to Rs 8.09 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 641% to Rs 9.13 crore, and PBT soared 36.72% to Rs 10.35 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 12.4 crore in FY26, as against Rs 10.7 crore in FY25. Sanjivani Paranteral Ltd crashed 9.99% in last one year, underperforming the benchmark BSE Sensex which has slipped by 3.05% during the same period.
Sanjivani Paranteral Ltd share price inched up 2.93% to Rs 191.45 after the company's net profit saw a strong growth of 352.73% to Rs 2.49 crore, while revenue from operations increased sharply by 80.47% to Rs 23.84 crore in Q2FY26 over Q1FY26. The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 25.19 lakh crore, rising 4.69%. It has marginally improved by 0.66% over last one week and climbed by 11.20% in last one month while the market capitalization of Sanjivani Paranteral Ltd has slipped by 0.91% and 40.46% in the same period respectively. Profit before tax (PBT) of Sanjivani Paranteral Ltd stood at Rs 3.32 crore in Q2 FY26, rallying 44.35% year-on-year, and surging by 176.67% quarter-on-quarter. EBITDA came in at Rs 4 crore, expanding by 54.62% YoY and jumping 310.20% sequentially. Total expenses surged 65.34% to Rs 20.32 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 15.67 crore, witnessing a sharp rise of 110.34% YoY, while employee benefits expense was at Rs 2.35 crore, easing 4.91% YoY. For the TTM ended FY26, revenue from operations jumped by 28.84% to Rs 70.1 crore, while net profit jumped 31.12% to Rs 8.09 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 641% to Rs 9.13 crore, and PBT soared 36.72% to Rs 10.35 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 12.4 crore in FY26, as against Rs 10.7 crore in FY25. Sanjivani Paranteral Ltd crashed 9.99% in last one year, underperforming the benchmark BSE Sensex which has slipped by 3.05% during the same period.